ATE240727T1 - Verwendung einer zusammensetzung enthaltend histaminphosphat zur herstellung eines medikaments zur topischen behandlung von epithelialen entzündungen oder läsionen - Google Patents

Verwendung einer zusammensetzung enthaltend histaminphosphat zur herstellung eines medikaments zur topischen behandlung von epithelialen entzündungen oder läsionen

Info

Publication number: ATE240727T1
Authority: AT; Austria
Prior art keywords: lesions; medication; producing; composition containing; topical treatment
Prior art date: 1994-03-02

Application number

AT94912176T

Other languages

English (en)

Inventor

Bruce A Jack

B Thomas White

Original Assignee

Professional Pharmaceutical In

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-03-02

Filing date

1994-03-02

Publication date

2003-06-15

1994-03-02 Application filed by Professional Pharmaceutical In filed Critical Professional Pharmaceutical In

2003-06-15 Application granted granted Critical

2003-06-15 Publication of ATE240727T1 publication Critical patent/ATE240727T1/de

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/417—Imidazole-alkylamines, e.g. histamine, phentolamine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Virology (AREA)
Epidemiology (AREA)
Dermatology (AREA)
Ophthalmology & Optometry (AREA)
Immunology (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Rheumatology (AREA)
Nutrition Science (AREA)
Pain & Pain Management (AREA)
Physiology (AREA)
Biotechnology (AREA)
Molecular Biology (AREA)
Inorganic Chemistry (AREA)
Pulmonology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)

AT94912176T 1994-03-02 1994-03-02 Verwendung einer zusammensetzung enthaltend histaminphosphat zur herstellung eines medikaments zur topischen behandlung von epithelialen entzündungen oder läsionen ATE240727T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
PCT/US1994/002282 WO1995023601A1 (en)	1994-03-02	1994-03-02	Method and composition for topical treatment of damaged tissue using histamine phosphate as active ingredient

Publications (1)

Publication Number	Publication Date
ATE240727T1 true ATE240727T1 (de)	2003-06-15

Family

ID=22242315

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT94912176T ATE240727T1 (de)	1994-03-02	1994-03-02	Verwendung einer zusammensetzung enthaltend histaminphosphat zur herstellung eines medikaments zur topischen behandlung von epithelialen entzündungen oder läsionen

Country Status (9)

Country	Link
EP (1)	EP0706394B1 (de)
JP (1)	JP3552168B2 (de)
AT (1)	ATE240727T1 (de)
CA (1)	CA2160779C (de)
DE (1)	DE69432703T2 (de)
DK (1)	DK0706394T3 (de)
ES (1)	ES2199961T3 (de)
PT (1)	PT706394E (de)
WO (1)	WO1995023601A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6270781B1 (en) *	1999-01-08	2001-08-07	Maxim Pharmaceuticals, Inc.	Method and compositions for topical treatment of damaged tissue using reactive oxygen metabolite production or release inhibitors
AU777655B2 (en) *	1999-06-03	2004-10-28	Maxim Pharmaceuticals, Inc.	Ophthalmic histamine compositions and uses thereof
WO2003082081A2 (en) *	2002-03-29	2003-10-09	Maxim Pharmaceuticals, Inc.	Use of rom production and release inhibitors to treat and prevent intraocular damage

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3898325A (en) *	1973-09-19	1975-08-05	American Lipids Corp	Method and preparations for relieving pain and producing analgesia
US4228176A (en) *	1979-04-09	1980-10-14	Nelson Research & Development Company	Thromboxane inhibition with burimamide
CA1163561A (en) *	1979-11-06	1984-03-13	Cyril Boroda	Preparation containing nitroglycerine and optionally other medicaments and preparation thereof
US4618490A (en) *	1980-06-06	1986-10-21	Marco Peter T De	Method of treatment of animal and human tissues damaged by burns and frank visible gangrene
US4966892A (en) *	1982-05-07	1990-10-30	Carrington Laboratories, Inc.	Processes for preparation of aloe products products produced thereby and compositions thereof
US4705685A (en) *	1982-05-17	1987-11-10	Mcmichael John	Methods and materials for treatment of disease states involving immunological factors
US5176912A (en) *	1991-01-29	1993-01-05	Orestes Cabezas	Method of treating psoriasis

1994
- 1994-03-02 EP EP94912176A patent/EP0706394B1/de not_active Expired - Lifetime
- 1994-03-02 CA CA002160779A patent/CA2160779C/en not_active Expired - Fee Related
- 1994-03-02 PT PT94912176T patent/PT706394E/pt unknown
- 1994-03-02 ES ES94912176T patent/ES2199961T3/es not_active Expired - Lifetime
- 1994-03-02 DE DE69432703T patent/DE69432703T2/de not_active Expired - Fee Related
- 1994-03-02 WO PCT/US1994/002282 patent/WO1995023601A1/en active IP Right Grant
- 1994-03-02 DK DK94912176T patent/DK0706394T3/da active
- 1994-03-02 JP JP52287495A patent/JP3552168B2/ja not_active Expired - Fee Related
- 1994-03-02 AT AT94912176T patent/ATE240727T1/de not_active IP Right Cessation

Also Published As

Publication number	Publication date
DE69432703T2 (de)	2004-03-25
DE69432703D1 (de)	2003-06-26
CA2160779C (en)	2008-08-26
CA2160779A1 (en)	1995-09-08
EP0706394A4 (de)	2000-06-28
JPH08509994A (ja)	1996-10-22
PT706394E (pt)	2003-10-31
DK0706394T3 (da)	2003-09-22
WO1995023601A1 (en)	1995-09-08
EP0706394A1 (de)	1996-04-17
EP0706394B1 (de)	2003-05-21
ES2199961T3 (es)	2004-03-01
JP3552168B2 (ja)	2004-08-11

Similar Documents

Publication	Publication Date	Title
ATE177629T1 (de)	1999-04-15	Verwendung von 2-hydroxycarbonsäure oder deren derivaten enthaltende zusammensetzung zur linderung von wechseln nagelveränderungen
EP0068552A3 (de)	1984-03-28	Topisches mikrobizides Präparat
YU6393A (sh)	1996-10-09	Novi derivati amidina i njihovo dobijanje
DE69710712D1 (de)	2002-04-04	Umkehrbare inhibitoren von tyrosin kinasen
DE59803845D1 (de)	2002-05-23	Sulfinsäurederivate und deren herstellung und verwendung
NO991731L (no)	1999-06-14	Lokalanestetika for utvortes bruk
DE69621104D1 (de)	2002-06-13	Verwendung einer ein Polymersystem enthaltenden Zubereitung
ATE8203T1 (de)	1984-07-15	Antineoplastische mittel auf basis von nicht oder nur geringfuegig irritierenden und/oder promovierenden diterpenalkoholen und derivaten davon und deren herstellung.
EP0257485A3 (de)	1989-10-11	Kombination von positiv inotrop wirkenden Dihydropyridinen mit ACE-Hemmern, sowie ihre Verwendung in Arzneimitteln
ATE240727T1 (de)	2003-06-15	Verwendung einer zusammensetzung enthaltend histaminphosphat zur herstellung eines medikaments zur topischen behandlung von epithelialen entzündungen oder läsionen
DE69301877D1 (de)	1996-04-25	Kosmetische oder dermatologische zusammensetzung in form einer öl-in-wasser dispersion, die verbundfilme bilden kann
DK0727996T3 (da)	2002-11-18	Fendazolformuleringer
ATE32071T1 (de)	1988-02-15	Cyclohexenonderivate, verfahren zu ihrer herstellung sowie ihre verwendung zur bekaempfung unerwuenschten pflanzenwuchses.
ES2137196T3 (es)	1999-12-16	Formulacion antiseborreica.
NO913331L (no)	1992-02-28	4-substituerte dihydropyrido(4,3-d)pyrimidiner for behandling av hudforstyrrelser.
MX9301723A (es)	1994-01-31	Derivados de carbinol di-arilo puenteados, composiciones y metodos de uso.
FR2358399A1 (fr)	1978-02-10	5-m-tolyloxy-uracile, agent anti-ulceres
FI920425A0 (fi)	1992-01-30	Cykloalkylenazoler, foerfarande foer deras framstaellning, dessa innehaollande farmaceutiska preparat och deras anvaendning vid framstaellning av laekemedel.
DE59100466D1 (de)	1993-11-11	Alkohol enthaltende wässrige gelartige phospholipidzusammensetzung, ihre verwendung und topische zubereitungen, die diese enthalten.
ES2055925T3 (es)	1994-09-01	Derivados de la 9-fluor-prostaglandina, procedimiento para su obtencion y su uso farmaceutico.
IE890484L (en)	1989-08-16	Antiulcer pyrimidine derivatives
ATE92063T1 (de)	1993-08-15	Verbrueckte bicyclische 4-(4-(3-benzisothiazolyl)1-piperazinyl)-butylimide mit antipsychotischer wirkung.
HSU et al.	1980	Studies on Dew II. On the Formation of Dew
Delaney et al.	1969	Functional group and substituent effects, both steric and electronic, upon the ultraviolet absorption spectra of some N-alkyl-and N, N-dialkyl-derivatives of some cinnamamides and benzalcyanoacetamides
NO921313L (no)	1992-04-03	Derivater av 2-spirocyklopropylcefalosporinsulfoner og deres fremstilling

Legal Events

Date	Code	Title	Description
2003-12-15	UEP	Publication of translation of european patent specification	Ref document number: 0706394 Country of ref document: EP
2010-12-15	REN	Ceased due to non-payment of the annual fee

Date

Code

Title

Description

2003-12-15

UEP

Publication of translation of european patent specification

Ref document number: 0706394

Country of ref document: EP

2010-12-15

REN

Ceased due to non-payment of the annual fee